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The present study was conducted to clarify the effects of coumestrol administration 16 
during pregnancy on Ca metabolism during pregnancy and in lactating mice. From 6.5 17 
to 16.5 days post coitus (dpc), pregnant mice were administered at 200 µg/kg body 18 
weight/day of coumestrol. The duodenum, jejunum and blood samples were obtained at 19 
17.5 dpc or 10 days after parturition (dap). Coumestrol administration decreased 20 
alkaline phosphatase (ALP) activity and mRNA expression of IAP and estrogen 21 
responsive genes, c-fos and vascular endothelial growth factor (VEGF), in the 22 
duodenum and jejunum of pre-delivery mice. In lactating mice, the ALP activity and 23 
mRNA expression of IAP were not changed, although coumestrol administration 24 
decreased mRNA expression of c-fos in the duodeum and VEGF in the jejunum. 25 
Coumestrol did not affect serum Ca and the expression of vitamin D receptor protein in 26 
the duodenum and jejunum. Thus, coumestrol administration during pregnancy may 27 
decrease the mRNA expression of IAP and the ALP activity in the intestine of the 28 
pre-delivery mice through ERα, but coumestrol had little effect on intestinal ALP 29 
activity at 10 days after parturition.  30 
 31 




INTRODUCTION  35 
Phytoestrogens are plant-derived compounds that have similar chemical structures to 36 
endogenous estrogens and the potential to mimic estrogen activity (Ososki and Kennelly, 37 
2003). These chemicals can compete with 17β-estradiol for binding to estrogen 38 
receptors (ERs), although their relative affinity to ERs and transcription activity are 39 
substantially less than those of endogenous estrogens. Because phytoestrogens may help 40 
to prevent carcinomas, heart diseases, osteoporosis and menopausal disorders (Ososki 41 
and Kennelly, 2003), it is expected that the phytoestrogens can be used for estrogen 42 
replacement therapy to improve the health status of humans and animals. 43 
Coumestrol, a phytoestrogen and the most prevalent coumestan derivatives, 44 
interacts with ERs most strongly in phytoestrogens and has various physiological effects 45 
through ERs in vivo and in vitro (Morito et al., 2002). Ca plays a crucial role in some 46 
targeted organs, and the demands for fetal accretion of Ca and output of milk are met by 47 
physiological changes in Ca metabolism during pregnancy and lactation, such as renal 48 
Ca conservation, increased Ca resorption from the skeleton or enhanced Ca absorption 49 
(Kovacs and Kronenberg, 1997). Estrogen plays some physiological role in Ca 50 
homeostasis through intestine, kidney and bone (Farhan and Sundeep, 2005). 51 
Coumestrol stimulates bone cells and exerts effective prevention against bone 52 
resorption in estrogen deficient rats (Ye et al., 2003).  53 
   Phytoestrogens can act as both estrogen agonists and antagonists (Ososki and 54 
Kennelly, 2003). The effects of oral administration of coumestrol at doses of 0.1 to 30 55 
mg/kg body weight have been examined in ovariectomized rats; ≥ 1 mg/kg body weight 56 
of coumestrol increased uterine weight, ≥ 10 mg/kg body weight increased bone mineral 57 
density of the tibia, and ≥ 100 µg/kg body weight lowered cholesterol in sera 58 
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significantly (Dodge et al., 1996). As of August 23, 2006, the Ministry of Health, 59 
Labour and Welfare of Japan recommends intake of up to 30 mg per day of soybean 60 
isoflavone. This corresponds to about 458-570 µg/kg body weight/day on the average 61 
body weight of Japanese adults. Based on less than half this limit for isoflavone intake, 62 
we previously examined the effects of coumestrol on Ca metabolism in the 63 
post-delivery mice given 200 µg/kg body weight/day during pregnancy and showed that 64 
coumestrol decreased activity of intestinal alkaline phosphatase (IALP) in both 65 
duodenum and jejunum at 1 day after birth (Kirihata et al., 2008). These results suggest 66 
that coumestrol at a dose of 200 µg/kg body weight antagonizes the effects of ER on 67 
expression of IAP mRNA, resulting in decreased activity of IALP in duodenum 68 
(Kirihata et al., 2008), but it is not clear whether coumestrol administration during 69 
pregnancy affects expression of IAP mRNA and activity of IALP in maternal mice 70 
before delivery and lactating mice. 71 
   The objective of this study was conducted to clarify the effect of coumestrol 72 
administration during pregnancy on Ca metabolism including IALP activity and 73 
expression of vitamin D Receptor (VDR) protein in pre-delivery and lactating mice in 74 
order to evaluate the role of phytoestrogen for Ca metabolism during periparturient 75 
period.  76 
 77 
MATERIALS AND METHODS 78 
Animals and coumestrol treatment. Pregnant ICR mice were obtained from Clea 79 
Japan (Tokyo, Japan), housed in polycarbonate cages and maintained in a 80 
temperature-controlled room (24±2 C) on a 14-h light (0500 h-1900 h)/ 10-h dark cycle. 81 
All animals were given free access to tap water and MF rodent feed (Oriental yeast, 82 
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Tokyo, Japan). They received humane care as outlined in the “Guide for the Care and 83 
Use of Laboratory Animals” (Kyoto University Animal Care Committee according to 84 
NIH No. 86-23; revised 1999) and “Regulation on Animal Experimentation at Kyoto 85 
University”.  86 
From 6.5 to 16.5 days post coitus (dpc), pregnant females were administered a daily 87 
dose of coumestrol (200 µg/kg body weight/day, oral gavage, 11 times; Toronto 88 
Research Chemicals, Tronro, ON, Canada) dissolved in ethanol (Wako Pure Chemicals, 89 
Osaka, Japan) and purified olive oil (Wako; CM group) or ethanol dissolved in purified 90 
olive oil (5 ml/kg/day) as vehicle control (VC group) at 1200 h-1300 h. As a normal 91 
control (NC group), pregnant females were kept under the same conditions without 92 
administration of either vehicle or coumestrol solution. The day on which pups were 93 
found in the morning was assigned as 1 day after parturition (dap), and the numbers of 94 
pups for each dam were reduced to 10 at 2 dap. At 17.5 dpc or 10 dap, blood samples 95 
were obtained for biochemical analysis by cardiac puncture under anesthesia by diethyl 96 
ether or avertin, and then the duodenum and jejunum were rapidly removed. Portions of 97 
these samples were immediately fixed in 10% neutral-buffered formalin (Wako) for 98 
immunohistochemistry and enzyme histochemistry. The remaining portions of these 99 
samples were frozen in liquid nitrogen and stored at –80 C for semi-quantitative reverse 100 
transcriptase-polymerase chain reaction (RT-PCR).  101 
 102 
Enzymehistochemical and immunohistochemical analyses. After formalin fixation, 103 
the duodenum and jejunum samples were dehydrated in a graded series of ethanol and 104 
embedded in paraffin (Histosec; Merck, Darmstadt, Germany). ALP activity and VDR 105 
protein expression in the duodenum and jejunum were examined using 106 
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enzymehistoshemical and immunohistochemical analyses, respectively. These analyses 107 
were conducted as previously described (Kirihata et al., 2008).  108 
 109 
Semi-quantitative RT-PCR.  Total RNA was extracted from homogenized duodenum 110 
and jejunum samples from maternal mice using an RNeasy Mini Kit (Qiagen, 111 
Germantown, MD, USA). Complementary DNA (cDNA) was synthesized with 112 
oligo-(dT) primer using a SuperScript III First-Strand Synthesis System for RT-PCR 113 
(Invitrogen, Calisbad, CA, USA) and 2 µg RNA from each sample. The cDNA was 114 
quick-chilled on ice to denature the RNA-cDNA duplex. PCR was performed using a 115 
Platinum Super Mix Kit (Invitrogen). All of the above procedures were performed 116 
according to each manufacturer’s protocol. The PCR products were electrophoresed in 117 
2% agarose gel and stained with 1 µg/ml ethidium bromide solution. A ready-load 100 118 
bp DNA ladder (Invitrogen) was used as a molecular weight marker for electrophoresis. 119 
After electrophoresis, the gels were recorded with a digital recorder, and then the 120 
mRNA expression levels were semiquantified using ImageJ software (National Institute 121 
of Health, Bethesda, MD, USA). The relative abundance of specific mRNA was 122 
normalized by the abundance of glyceraldehydes 3-phophate dehydrogenase (GAPDH) 123 
mRNA. The primer pairs and PCR conditions used for IAP, c-fos, VEGF, VDR, 124 
epithelial Ca channel 1 (ECaC1), ECaC2 and GAPDH are same as those in the previous 125 
study (Kirihata et al., 2008).  126 
 127 
Biochemical analysis. Each blood sample was stabilized at room temperature for 1 h 128 
and then centrifuged at 3000 rpm for 15 min. The serum was fractionated, and the 129 
serum Ca and inorganic phosphorus (Pi) levels were measured using an automatic 130 
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analyzer (Fuji Drychem 3500 V; Fuji Film, Tokyo, Japan) according to manufacturer’s 131 
instructions. 132 
 133 
Statistical analysis. Statistical analysis was carried out by analysis of variance. This 134 
test was used to evaluate the interaction among three groups. When a difference among 135 
three groups was shown, the two-independent-sample t-test was applied to evaluate 136 
whether or not the difference was a treatment effect. Differences of P<0.05 were 137 
considered significant. 138 
 139 
RESULTS 140 
Intestinal ALP activity 141 
ALP activity was detected on the surface of the epithelia of villi and upper crypts. ALP 142 
activity weakened in the apical region of villi. ALP activity was not detected in the 143 
Brunner’s glands in the duodenums. At 17.5 dpc, the duodenums of the CM group (Fig. 144 
1c) showed weaker activity than those of the NC (Fig. 1a) and VC groups (Fig. 1b). In 145 
the jejunum, coumestrol also decreased ALP activity (Fig. 1d-f). In contrast, no 146 
remarkable differences were detected among the NC, VC and CM groups in both of the 147 
duodenum and the jejunum at 10 dap.  148 
 149 
Intestinal VDR expression 150 
No remarkable differences were detected in intestinal VDR expression in the duodenum 151 
and jejunum among the NC, VC and CM groups at 17.5 dpc and at 10 dap (not shown). 152 
In the duodenums, VDR was expressed strongly in the entire epithelium of villi 153 
compared with in the epithelium of the jejunum and scattered in the Brunner’s glands. 154 
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In the jejunums, VDR expression was detected in the entire epithelia of villi and crypts 155 
and declined from the villi top to the villi stem.  156 
 157 
Intestinal mRNA expression  158 
IAP, c-fos and VEGF mRNA was expressed both in the duodenum and jejunum. At 17.5 159 
dpc, coumestrol administration decreased the mRNA expression of IAP, c-fos and 160 
VEGF compared with the NC and VC groups in the duodenum and jejunum (P<0.05; 161 
jejunum, P<0.01; duodenum; Table 1). At 10 dap, there were no significant differences 162 
in IAP mRNA expression in the duodenum and jejunum among the NC, VC and CM 163 
groups, but expression of c-fos in the duodeum and VEGF in the jejunum were 164 
decreased in CM group. VDR and ECaC2 mRNA was expressed in the duodenum and 165 
jejunum, but ECaC1 mRNA was not expressed. No significant differences were 166 
detected in VDR and ECaC2 mRNA expression among the NC, VC and CM groups at 167 
17.5 dpc and at 10 dap (data not shown).  168 
 169 
Serum Ca and Pi 170 
No significant differences were detected in the serum Ca and Pi levels among the 171 
groups at 17.5 dpc and at 10 dap (Table 2).  172 
 173 
DISCUSSION 174 
Estrogen regulates expression of some genes related to Ca metabolism, such as ALP 175 
and VDR. Intestinal ALP, which is encoded by IAP gene, increases Ca absorption in the 176 
jejunum and duodenum (Dulpuis et al., 1991; Halloran and De luca, 1981). Estrogen 177 
regulates activity and mRNA expression of IALP in rats (Matsumoto et al., 1997) and 178 
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estrogen responsive genes, c-fos and VEGF, in mice (Hyder et al., 1991; Wang et al., 179 
2009). Coumestrol has been shown to be an oestrogen agonist (Dodge et al., 1996; 180 
Jefferson et al., 2002; Kanno et al., 2004; Ye et al., 2003), and phytoestrogens increase 181 
intestinal Ca uptake via enhancement of ALP activity in ovariectomized mice 182 
(Mukherjee et al., 2006).  183 
In this study, however, coumestrol at a dose of 200 µg/kg body weigh during 184 
pregnancy caused a decrease in IALP activity and mRNA expression of IAP, c-fos and 185 
VEGF in duodenum and jejunum of pre-delivery mice, although serum Ca and 186 
expression of VDR protein in the small intestine were not affected. Because 187 
phytoestrogens (at 100-1000 times of estradiol) compete effectively with endogenous 188 
estrogens, bind to the ER and prevent estrogen-stimulated growth in mammals (Kurzer 189 
and Xu, 1997), the effects of phytoestrogens on ALP activity may be related to the level 190 
of endogenous estrogen. In general, pregnancy induces a dramatic rise in estrogen, and 191 
serum estrogen increases with gestation but decreases after parturition. According to the 192 
previous (Kirihata et al., 2008) and present studies, coumestrol administration during 193 
pregnancy decreased the expression of IAP, c-fos and VEGF mRNA in both duodenum 194 
and jejunum at 17.5 dpc and only in duodenum at 1 dap, resulting in the decreased 195 
activity of IALP in both duodenum and jejunum at 17.5 dpc and 1 dap. Thus, in the 196 
presence of high level of endogenous estrogen in mice before parturition, coumestrol 197 
administration may interrupt the ER-derived increase of ALP activity in mice around 198 
parturition. However, the antagonistic effects of coumestrol may not be maintained for 199 
lactating mice, because coumestrol administration had little effect on IALP activity in 200 
mice at 10 days after parturition.   201 
Vitamin D and VDR also play important roles in Ca metabolism via regulation of 202 
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ECaCs and IAP transcriptionally and the expression of VDR is regulated by estrogen 203 
(Bouillon et al., 2003). In this study, the VDR protein expression and the expressions of 204 
VDR and ECaC2 mRNA in mice were not affected by the administration of coumestrol, 205 
which agreed with the previous study (Kirihata et al., 2008). The expression of VDR 206 
mRNA is mediated by ERβ in human and rats, while the expression of murine c-fos and 207 
VEGF are induced by ERα dependent pathway (Jelinsky et al., 2003; Wang et al., 208 
2009). It has been reported that the estrogen-antagonistic action of coumestrol observed 209 
in mouse brain is mediated by ERα (Jacob et al., 2001) and ERα mRNA expression is 210 
much more abundant in murine duodenum than ERβ (Duan et al., 2006; Kanno et al., 211 
2004; Smith et al., 2008). Our results suggest that coumestrol regulates the expression 212 
of IAP mRNA and the activity of IALP through ERα in mice. 213 
Recent studies in IALP deficient mice reported that lack of IALP does not result in 214 
Ca mal-absorption (Narisawa et al., 2003) but impairs intestinal barrier function 215 
(Goldberg et al., 2008). Because serum levels of Ca in mice were unchanged at 17.5 dpc, 216 
1dap and 10 dap by coumestrol administration in both a previous (Kirihata et al., 2008) 217 
and the present study, it can be concluded that coumestrol at a dose of 200 µg/kg body 218 
weight during pregnancy does not have a significant effect on Ca metabolism in 219 
periparturient mice. However, laboratory studies in developmental animals have 220 
demonstrated the potential for adverse effects following exposure to high levels of soy 221 
isoflavones, although perimenopausal and early menopausal women may be more 222 
receptive to the therapeutic effects of isoflavones on bone loss prior to the diminution of 223 
ERs (Reinward and Weaver, 2006). Thus, feeding large amounts of phytoestrogen may 224 
be not recommended for pregnant animals, especially in pre-delivery periods, to prevent 225 
adverse effects on Ca metabolism. 226 
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In summary, coumestrol administration during pregnancy may decrease the 227 
expression of IAP mRNA and the activity of IALP in the intestine of the pre-delivery 228 
mice through ERα, but coumestrol had little effect on IALP activity at 10 days after 229 
parturition.   230 
 231 
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Figure legend 308 
 309 
Figure 1.  Alkaline phosphatase activity in the duodenums (a-c) and jejunums (d-f) of 310 
mice at 17.5 dpc in the normal control (a, d), vehicle control (b, e) and coumestrol (c, f) 311 
groups. Blue stains reflect alkaline phosphatase activity. Bars = 10 µm. V, villi; C, 312 






Table 1.  The IAP/GAPDH, c-fos/GAPDH and 
VEGF/GAPDH ratio among three groups in the duodenum 
and jejunum at 17.5 dpc and 10 dap. 
Genes NC VC CM 
IAP       
 at 17.5 dpc    
    Duodenum 0.60 ± 0.14 0.63 ± 0.22 0.32 ± 0.10** 
    Jejunum 0.94 ± 0.19 0.98 ± 0.20 0.69 ± 0.23* 
 at 10 dap    
    Duodenum 1.59 ± 0.19 1.61 ± 0.18 1.67 ± 0.30 
    Jejunum 0.95 ± 0.12 1.19 ± 0.13 1.10 ± 0.15 
c-fos       
 at 17.5 dpc    
    Duodenum 0.75 ± 0.14 0.68 ± 0.17 0.40 ± 0.12** 
    Jejunum 0.64 ± 0.29 0.61 ± 0.21 0.39 ± 0.11* 
 at 10 dap    
    Duodenum 1.25 ± 0.27 1.31 ± 0.24 0.46 ± 0.12* 
    Jejunum 0.80 ± 0.14 1.03 ± 0.11 0.50 ± 0.15 
VEGF    
 at 17.5 dpc    
    Duodenum 0.41 ± 0.09 0.34 ± 0.07 0.22 ± 0.04** 
    Jejunum 0.61 ± 0.20 0.64 ± 0.22 0.30 ± 0.09* 
 at 10 dap    
    Duodenum 1.30 ± 0.21 1.09 ± 0.17 1.23 ± 0.32 
    Jejunum 0.86 ± 0.14 0.86 ± 0.10 0.42 ± 0.12* 
Each value represents the mean value±SE (n=9 per group at 
17.5 dpc and n=11 per group at 10 dap). 
 *: P<0.05 vs. NC, **: P<0.01 vs. NC.  







Table 2. Serum Ca and Pi among the three groups at 17.5 dpc 
and 10dap. 
Parameters       
NC VC CM 
 at 17.5 dpc       
  Ca(mg/dl) 10.79 ± 0.49 10.62 ± 0.80 10.31 ± 0.71 
  Pi(mg/dl) 9.49 ± 2.24  7.69 ± 1.69 9.18 ± 1.93 
 at 10 dap    
  Ca(mg/dl) 10.27 ± 0.45 10.02 ± 0.47 10.19 ± 0.42 
  Pi(mg/dl) 9.58 ± 0.68 9.36 ± 0.78 8.70 ± 0.53 
Each value represents the mean value ±SE (n=9 per group at 
17.5 dpc and n=15 per group at 10 dap).  
NC, normal control; VC, vehicle control; CM, coumestrol 
 323 
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Figure 1
